FLT3 and acute myeloid leukemia: We next evaluated the in vivo efficacy of SNDX-5613 and adavosertib versus each drug alone or vehicle control in NSG mice tail-vein engrafted with a separate and aggressive mtNPM1-FLT3-ITD AML PDX model that also harbored FLT3-F691L TKD.